PharmacyCodes



DEA No. 1670 en es it fr

DEA No. 1670 Brand names, DEA No. 1670 Analogs

DEA No. 1670 Brand Names Mixture

  • No information avaliable

DEA No. 1670 Chemical_Formula

C12H16F3N

DEA No. 1670 RX_link

http://www.rxlist.com/cgi/generic/fenflur.htm

DEA No. 1670 fda sheet

DEA No. 1670 msds (material safety sheet)

DEA No. 1670 Synthesis Reference

No information avaliable

DEA No. 1670 Molecular Weight

231.257 g/mol

DEA No. 1670 Melting Point

108-112 oC at 1.20E+01 mm Hg

DEA No. 1670 H2O Solubility

412 mg/L

DEA No. 1670 State

Liquid

DEA No. 1670 LogP

3.74

DEA No. 1670 Dosage Forms

Capsule (sustained-release); Tablet

DEA No. 1670 Indication

For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.

DEA No. 1670 Pharmacology

Used to treat diabetes and obesity, Fenfluramine decreases caloric intake by increasing serotonin levels in the brain's synapses. Fenfluramine acts as a serotonin reuptake inhibitor. It also causes release of serotonin from the synaptosomes.

DEA No. 1670 Absorption

No information avaliable

DEA No. 1670 side effects and Toxicity

No information avaliable

DEA No. 1670 Patient Information

No information avaliable

DEA No. 1670 Organisms Affected

Humans and other mammals